Dried yeast tablets
Yeast allergenic extract is used in allergenic testing.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Yeast
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(3)
Fungitell for antifungal treatment stratification (MIB118)
Vitamin B12 deficiency in over 16s: diagnosis and management (NG239)
Clostridioides difficile infection: antimicrobial prescribing (NG199)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 41 · Randomised trials: 2 · 1989–2026
Showing the 50 most relevant studies, sorted by most relevant.
M. G. Lambrechts, I. Pretorius
South African Journal of Enology & Viticulture, 2019
Zekun Tao, Hai-Bo Yuan, Meng Liu, et al.
Journal of Microbiology and Biotechnology, 2022
M. Jach, A. Serefko, M. Ziaja, et al.
Metabolites, 2022
G. Shurson
Animal Feed Science and Technology, 2018
L. De Vuyst, Henning Harth, S. Van Kerrebroeck, et al.
International journal of food microbiology, 2016
Maria C. Dzialo, Rahel Park, Jan Steensels, et al.
FEMS Microbiology Reviews, 2017
S. Hammer, J. Avalos
Nature chemical biology, 2017
Irene Stefanini
Yeast (Chichester, England), 2018
Quinten Deparis, Arne Claes, Maria R Foulquié-Moreno, et al.
FEMS Yeast Research, 2017
Alagbe EO, Adeola O, Aderibigbe AS
2026
The restriction of antibiotic growth promoter use in poultry production has increased interest in alternatives such as yeast and yeast-derived products. However, studies on yeast supplementation have reported inconsistent results. Hence, this study evaluated the effects of dietary yeast supplementation on the growth performance and intestinal morphology of broiler chickens using a meta-analysis and meta-regression approach. A systematic search conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; 2020) guidelines across three databases found 1,397 records, and 41 controlled broiler studies that met the inclusion criteria. Subgroup analysis, meta-regression, heterogeneity, and robustness to publication bias tests were all performed. Yeast supplementation significantly improved body weight gain (mean difference (MD) = 72.8; 95% CI: 58.2 to 87.4; P< 0.001) and feed conversion ratio (MD = 0.055; 95% CI: 0.045 to 0.065; P< 0.001), indicating consistent benefits for growth performance and feed efficiency. Feed intake was not affected (MD = 3.57; 95% CI: -17.6 to 24.7; P= 0.741), suggesting that improvements in growth may be primarily driven by enhanced nutrient utilization rather than increased feed consumption. Intestinal morphology was also positively affected, with increased villus height (MD = 89.7; P< 0.001), improved crypt depth (MD = 24.1; P< 0.001), and a higher villus height-to-crypt depth ratio (MD = 1.57; P< 0.001), indicating beneficial effects on gut health. Subgroup analysis showed that Arbor Acres birds had the greatest improvement in villus height (P< 0.001). Meta-regression analysis revealed that yeast inclusion dose significantly influenced growth performance and intestinal villus height (P< 0.001). Publication bias assessment confirmed the robustness of the body weight gain, feed conversion ratio, villus height, crypt depth, and villus height-to-crypt depth ratio results. Overall, these findings support yeast supplementation as an effective feed additive in broiler chicken production, with consistent improvements in growth and intestinal morphology. Therefore, this study reinforces its potential role as an alternative to antibiotic growth promoters.
Abstract licence: CC BY-NC-ND
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
ATC A07FA02
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Yeast
DrugBank citations
If you use DrugBank data in your research, please cite:
- DrugBank 6.02024Recommended citationKnox C., Wilson M., Klinger C.M., et alDrugBank 6.0: the DrugBank Knowledgebase for 2024Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275
- DrugBank 5.02018Wishart D.S., Feunang Y.D., Guo A.C., et alDrugBank 5.0: a major update to the DrugBank database for 2018Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082
- DrugBank 4.02014Law V., Knox C., Djoumbou Y., et alDrugBank 4.0: shedding new light on drug metabolismNucleic Acids Res. 2014 Jan 142(1):D1091-7
- DrugBank 3.02011Knox C., Law V., Jewison T., et alDrugBank 3.0: a comprehensive resource for 'omics' research on drugsNucleic Acids Res. 2011 Jan39(Database issue):D1035-41
- DrugBank 2.02008Wishart D.S., Knox C., Guo A.C., et alDrugBank: a knowledgebase for drugs, drug actions and drug targets.Nucleic Acids Research2008 Jan36(Database issue):D901-6
- DrugBank 1.02006Wishart D.S., Knox C., Guo A.C., et alDrugBank: a comprehensive resource for in silico drug discovery and exploration.Nucleic Acids Research2006 Jan 134(Database issue):D668-72